IEP 📈 Icahn Enterprises - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4511001012

IEP: Investments, Energy, Auto Parts, Packaging, Real Estate, Home Goods, Pharmaceuticals

Icahn Enterprises L.P. operates a diverse range of businesses, both domestically and internationally, through its various subsidiaries. The company's investment segment utilizes its proprietary capital to invest in private investment funds, providing a range of investment advisory and related services to its clients. This allows the company to leverage its expertise and resources to generate returns on its investments. Additionally, the investment segment provides a platform for the company to identify and capitalize on new investment opportunities, further diversifying its portfolio.

The energy segment is a significant contributor to the company's operations, refining and marketing transportation fuels such as gasoline and diesel, as well as renewable diesel. This segment also manufactures nitrogen fertilizers, including urea ammonium nitrate and ammonia, which are essential for the agricultural industry. The company's energy segment is well-positioned to capitalize on the ongoing demand for energy and agricultural products, and its diversified product offerings help to mitigate risks associated with fluctuations in commodity prices.

The automotive segment is another key area of focus for the company, with operations spanning the sale of automotive parts and materials, retailing of merchandise, and provision of repair and maintenance services. The company also leases real estate properties, generating additional revenue streams. This segment benefits from the ongoing demand for automotive products and services, and the company's diversified offerings help to reduce its dependence on any one particular market or customer segment.

The food packaging segment produces and sells a range of casings, including cellulosic, fibrous, and plastic products, which are used to prepare and package processed meat products. This segment is an important supplier to the food processing industry, and its products are used by a wide range of customers. The company's food packaging segment is well-positioned to capitalize on the ongoing demand for convenient and processed food products, and its diversified product offerings help to mitigate risks associated with fluctuations in demand.

The real estate segment is involved in a range of activities, including the leasing of land, retail, office, and industrial properties, as well as the development and sale of single-family homes. The company also operates country clubs, generating additional revenue streams. This segment benefits from the ongoing demand for real estate and recreational facilities, and the company's diversified offerings help to reduce its dependence on any one particular market or customer segment. The company's real estate segment is well-positioned to capitalize on the ongoing recovery in the housing market, and its diversified product offerings help to mitigate risks associated with fluctuations in demand.

The home fashion segment manufactures, sources, markets, distributes, and sells a range of home fashion consumer products. This segment is an important supplier to the retail industry, and its products are used by a wide range of customers. The company's home fashion segment is well-positioned to capitalize on the ongoing demand for home decor and furniture products, and its diversified product offerings help to mitigate risks associated with fluctuations in demand. The company's ability to design, manufacture, and distribute its products allows it to respond quickly to changes in consumer preferences and trends.

The pharma segment offers a range of pharmaceutical products and services, catering to the needs of the healthcare industry. This segment is an important supplier to the pharmaceutical industry, and its products are used by a wide range of customers. The company's pharma segment is well-positioned to capitalize on the ongoing demand for pharmaceutical products, and its diversified product offerings help to mitigate risks associated with fluctuations in demand. The company's ability to develop, manufacture, and distribute its products allows it to respond quickly to changes in the healthcare industry and consumer needs.

Icahn Enterprises L.P. has a long history of operations, dating back to its incorporation in 1987. The company is headquartered in Sunny Isles Beach, Florida, and its common stock is listed on the NASDAQ under the ticker symbol IEP. The company's ISIN is US4511001012, and it is classified as an industrial conglomerate under the GICS sub-industry classification. With its diversified range of businesses and operations, the company is well-positioned to capitalize on growth opportunities across a range of industries and markets. More information about the company can be found on its website at https://www.ielp.com.

Additional Sources for IEP Stock

IEP Stock Overview

Market Cap in USD 4,990m
Sector Energy
Industry Oil & Gas Refining & Marketing
GiC Sub-Industry Industrial Conglomerates
IPO / Inception 1987-05-18

IEP Stock Ratings

Growth 5y -71.9%
Fundamental 22.1%
Dividend 43.8%
Rel. Strength Industry -219
Analysts 5/5
Fair Price Momentum 14.29 USD
Fair Price DCF 20.99 USD

IEP Dividends

Dividend Yield 12m 36.73%
Yield on Cost 5y 13.47%
Annual Growth 5y -5.59%
Payout Consistency 58.0%

IEP Growth Ratios

Growth Correlation 3m -86%
Growth Correlation 12m -53.8%
Growth Correlation 5y -38.8%
CAGR 5y -18.14%
CAGR/Mean DD 5y -0.69
Sharpe Ratio 12m -0.81
Alpha -54.16
Beta 0.75
Volatility 32.13%
Current Volume 1348.1k
Average Volume 20d 1055.9k
What is the price of IEP stocks?
As of December 21, 2024, the stock is trading at USD 9.53 with a total of 1,348,100 shares traded.
Over the past week, the price has changed by -5.64%, over one month by -13.52%, over three months by -23.28% and over the past year by -25.27%.
Is Icahn Enterprises a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Icahn Enterprises is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 22.13 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IEP as of December 2024 is 14.29. This means that IEP is currently undervalued and has a potential upside of +49.95% (Margin of Safety).
Is IEP a buy, sell or hold?
Icahn Enterprises has received a consensus analysts rating of 5.00. Therefor, it is recommend to buy IEP.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0
What are the forecast for IEP stock price target?
According to ValueRays Forecast Model, IEP Icahn Enterprises will be worth about 15.4 in December 2025. The stock is currently trading at 9.53. This means that the stock has a potential upside of +62.01%.
Issuer Forecast Upside
Wallstreet Target Price 15 57.4%
Analysts Target Price 27 183.3%
ValueRay Target Price 15.4 62%